Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khaled Hani Aburisheh has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Documented but Not Demonstrably Performed: A Retrospective Audit of Routine NRS-2002 Screening Records in Hospitalized Adults with Diabetes

    byĀ Nawaf W. Alruwaili, Ali M. Alnughaimish, Khaled H. Aburisheh, Abdulmajeed Altamimi, Abdulaziz Alkhathaami, Aljazi Bin Zarah, Nora Alafif

    Background/Objectives: Nutritional-risk screening at admission is mandatory in many hospitals but is rarely audited. We audited routine Nutritional-Risk Screening 2002 (NRS-2002) records entered by nurses with mandatory training and credentialed access in hospitalized adults with diabetes. Methods: Retrospective, records-based audit of all eligible admissions (2020–2025) at a Saudi tertiary center. Routine items were extracted verbatim, and dietitians re-scored each admission from the same record using a common written procedure. Results: Of 650 admissions assessed, 131 were excluded (46 with no form opened; 85 with incomplete clinical data). Of 519 analyzed forms, 446 (85.9%) carried zero on every item and 22 (4.2%) contained any substantive item; of 73 non-zero totals, 41 comprised the age item alone and 11 could not be derived from their items. Among 83 admissions in which a charted body-mass index below 20.5 kg/m2 made the full screen mandatory, 79 (95.2%) had no substantive item. Any entry was present in 70.8% of patients aged ≄70 years versus 5.9% of younger patients, although indications for the full screen were less frequent in older patients. Re-scoring classified 124 admissions (23.9%, 95% CI 20.4–27.7) at NRS-2002-defined risk versus one routinely; 123 (99.2%) were unrecognized. Scoring diabetes itself as disease severity 1 left this unchanged; an extreme lower-bound rule gave 57 (11.0%), none recognized. Conclusions: Routine documentation was strongly suggestive of incomplete NRS-2002 implementation despite mandatory training. Its causes cannot be determined from the records; workflow-embedded completion, automated referral, and routine audit warrant prospective evaluation.

  • Open Access

    Left Ventricular Diastolic Dysfunction and Its Predictive Factors Among Saudi Patients With Type 2 Diabetes Mellitus

    byĀ Reem A. Aldhahi, Mazen M. Barhoush, Dina S. Almunif, Mohammed Jamal M. Anabi, Khaled H. Aburisheh

    Background: Diabetes mellitus places a significant burden on society in terms of healthcare expenditures and poor health outcomes and complications. Heart failure is one of its complications which increases morbidity and mortality for patients with diabetes. The purpose of this study was to assess the prevalence of left ventricular diastolic dysfunction (LVDD) and its predictors among Saudi patients with type 2 diabetes mellitus (T2DM). Methods: This retrospective cross-sectional study was conducted between May 2021 and May 2022 at King Saud University Medical City in Riyadh, Saudi Arabia. Medical records of adult patients with T2DM without prior cardiovascular disease who underwent echocardiographic examination were reviewed, and data were extracted. Echocardiographic findings were reviewed for the diagnosis of LVDD. Results: A total of 251 participants were included in the study. LVDD was diagnosed in 66.9% of the participants. The majority (89.9%) had grade I. The mean age was 59 ± 9.1 years and the mean diabetes duration was 20 ± 8.5 years. Of the patients, 76.9% had hypertension and 81.2% had dyslipidemia. The mean body mass index was 32.9 ± 6.6 kg/m2 and the mean glycated hemoglobin level was 7.7±2.3%. LVDD correlated with older age, longer duration of diabetes, obesity, poor glycemic control, higher systolic blood pressure, the presence of hypertension, and the usage of antihypertensive and lipid-lowering medications. In logistic regression analysis, older age and higher body mass index were the only independent risk factors of LVDD. Conclusion: The prevalence of LVDD among Saudi patients with T2DM was high. It was associated significantly with age and obesity. These findings highlight the need for early monitoring, and treatment to prevent its progression and reduce morbidity and mortality.

  • Open Access

    Early Detection of Type 1 Diabetes in First-Degree Relatives in Saudi Arabia (VISION-T1D): Protocol for a Pilot Implementation Study

    byĀ Iman S Algadi, Yazed AlRuthia, Muhammad H Mujammami, Khaled Hani Aburisheh, Metib Alotaibi, Sharifah Al Issa, Amal A Al-Saif, David Seftel, Cheng-Ting Tsai, Reem A Al Khalifah

    Background: Type 1 diabetes (T1D) is a growing global health concern, with a notable rise in incidence in Saudi Arabia. Despite the potential benefits of early detection through screening programs, such initiatives are currently lacking in Saudi Arabia and other Arab countries. Objective: This study aims to evaluate the feasibility, acceptability, and cost-effectiveness of a T1D-screening program targeting high-risk individuals, specifically children with a first-degree relative diagnosed with T1D. Methods: The VISION-T1D program is a prospective cohort study focused on the early detection of presymptomatic T1D by screening children aged 2-18 years. The primary screening method involves testing for islet autoantibodies, including insulin autoantibodies, glutamic acid decarboxylase autoantibodies, insulinoma associated-2 autoantibodies, and zinc transporter-8 autoantibodies. Optional genetic testing, including human leukocyte antigen phenotyping and the genetic risk score, is offered. Outcomes include the feasibility of the screening process, prevalence of early-stage T1D, psychological impacts, educational intervention effectiveness, progression rates to stage-3 T1D, and economic viability. Results: The VISION-T1D program began in May 2024. As of December 2024, a total of 176 families have been enrolled. Data collection will continue until April 2025, with final data analysis projected for mid-2025. Conclusions: The VISION-T1D study provides a practical approach to T1D screening tailored to the health care landscape of Saudi Arabia. The insights gained from this pilot program will inform the development of a national, population-based screening initiative designed to reduce diabetic ketoacidosis at diagnosis, improve long-term outcomes, and alleviate the economic burden of T1D. The VISION-T1D initiative could also serve as a scalable and sustainable model that can be adopted internationally, contributing to global efforts to manage and prevent T1D. Trial Registration: ClinicalTrials.gov NCT06513247; https://clinicaltrials.gov/study/NCT06513247 International Registered Report Identifier (IRRID): DERR1-10.2196/70575


  • Open Access

    Early Detection of Type 1 Diabetes in First-Degree Relatives in Saudi Arabia (VISION-T1D): Protocol for a Pilot Implementation Study (Preprint)

    byĀ Iman S Algadi, Yazed AlRuthia, Muhammad H Mujammami, Khaled Hani Aburisheh, Metib Alotaibi, Sharifah Al Issa, Amal A Al-Saif, David Seftel, Cheng-Ting Tsai, Reem A Al Khalifah

    BACKGROUND Type 1 diabetes (T1D) is a growing global health concern, with a notable rise in incidence in Saudi Arabia. Despite the potential benefits of early detection through screening programs, such initiatives are currently lacking in Saudi Arabia and other Arab countries. OBJECTIVE This study aims to evaluate the feasibility, acceptability, and cost-effectiveness of a T1D-screening program targeting high-risk individuals, specifically children with a first-degree relative diagnosed with T1D. METHODS The VISION-T1D program is a prospective cohort study focused on the early detection of presymptomatic T1D by screening children aged 2-18 years. The primary screening method involves testing for islet autoantibodies, including insulin autoantibodies, glutamic acid decarboxylase autoantibodies, insulinoma associated-2 autoantibodies, and zinc transporter-8 autoantibodies. Optional genetic testing, including human leukocyte antigen phenotyping and the genetic risk score, is offered. Outcomes include the feasibility of the screening process, prevalence of early-stage T1D, psychological impacts, educational intervention effectiveness, progression rates to stage-3 T1D, and economic viability. RESULTS The VISION-T1D program began in May 2024. As of December 2024, a total of 176 families have been enrolled. Data collection will continue until April 2025, with final data analysis projected for mid-2025. CONCLUSIONS The VISION-T1D study provides a practical approach to T1D screening tailored to the health care landscape of Saudi Arabia. The insights gained from this pilot program will inform the development of a national, population-based screening initiative designed to reduce diabetic ketoacidosis at diagnosis, improve long-term outcomes, and alleviate the economic burden of T1D. The VISION-T1D initiative could also serve as a scalable and sustainable model that can be adopted internationally, contributing to global efforts to manage and prevent T1D. CLINICALTRIAL ClinicalTrials.gov NCT06513247; https://clinicaltrials.gov/study/NCT06513247 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/70575

  • Open Access

    New Onset of Type 1 Diabetes Mellitus Post-COVID-19 Vaccine

    byĀ Khaled H. Aburisheh, Hamza M.K. Enabi, Nora A. Alodah, Bassam H. Alotary, Linah A. Algheryafi, Ayman M. Almairi, Amani A. Aldhewaila

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with an increased morbidity and mortality worldwide. Coronavirus disease 2019 (COVID-19) vaccines have shown high efficacy in preventing the infection but with many possible side effects such as hyperglycemia. New-onset diabetes mellitus (DM) and severe metabolic complications have been reported post-vaccination. Here we report a 45-year-old woman who came to the hospital complaining of polyurea, polydipsia, and weight loss 3 weeks after the first activation dose of COVID-19 vaccine. Her hemoglobin A1c (HbA1c) upon presentation was 9% without any prior history of DM. She was diagnosed with type 1 diabetes mellitus (T1DM), as the anti-glutamic acid decarboxylase (GAD) antibody was positive and complicated during follow-up with diabetic ketoacidosis (DKA). This is the first case in Saudi Arabia suggesting that the COVID-19 RNA-based vaccines might cause new onset of T1DM, complicated by late DKA.


  • Open Access

    Sleep Quality Assessment and Its Predictors Among Saudi Adults with Type 1 and Type 2 Diabetes: A Cross-Sectional Study

    byĀ Abdulaziz A. Alhoqail, Khaled H. Aburisheh, Abdulrahman M. Alammar, Mohammed A. Bin Mugren, Abdulrahman M. Shadid, Ibrahim K. Aldakhil, Hamza M. K. Enabi, Faisal N. Alotaibi

    Background: Poor sleep quality is prevalent among adults with diabetes, impacting their physical, psychological, and functional well-being. Our goals were to assess the prevalence of poor sleep quality and its association with glycemic control and to identify predictors of poor sleep quality among adults with diabetes mellitus. Methods: This cross-sectional study took place at a tertiary hospital, from October 2022 to March 2023, including 192 adults with type 1 and type 2 diabetes. We collected demographic and clinical data and utilized the Pittsburgh Sleep Quality Index (PSQI) scale to evaluate sleep quality. Results: A total of 65.9% of the participants experienced poor sleep quality (PSQI score > 5), with an average global sleep quality score of 7.36 ± 3.53 for all patients. Poor sleep quality was higher among older and married patients, those with lower education levels, housewives, and those with type 2 diabetes mellitus and associated comorbidities, such as hypertension and dyslipidemia. None of these factors were significantly associated with sleep quality in a multiple linear regression analysis. The mean glycated hemoglobin was 8.68 ± 1.91% and did not correlate with the overall PSQI score and its components. Conclusions: This study revealed a notably high prevalence of poor sleep quality among Saudi adults with diabetes, potentially associated with specific sociodemographic and clinical factors. These findings emphasize the importance of integrating sleep quality education into diabetes management strategies.


  • Open Access

    The impact of physician communication skills on glycemic control in patients with diabetes mellitus

    byĀ Faisal Nahes Alotaibi, Khaled Hani Aburisheh, Abdulelah Ibrahim Alrasheed, Alwaleed Khalaf Alazmi, Khalid Dhaifallah Alamri, Nawaf Nahes Alotaibi, Anas Nahes Alotaibi, Abdulaziz Abdulkarem Alhoqail

    Objectives: The purpose of the study was to evaluate the impact of physicians’ communication skills on glycemic control in type I and II diabetes patients.Method: This cross-sectional study was conducted at the diabetic center at King Saud University Medical City, Riyadh, Saudi Arabia. The Arabic version of the communication assessment tool was used to evaluate the patient’s perception of the physicians’ communication skills.Results: A total of 348 patients were invited to participate in the study in which 332 filled the questionnaire completely and hence participation rate was 95.4%. The average age of the patients was 44.2 (±19.7) years with an almost equal gender ratio. The percentage of excellent ratings for most of the questions was varying between 70 and 80%. The overall percentage of excellent ratings was 75.3%. Glycated hemoglobin and other metabolic features except for diastolic blood pressure did not have any significant association with the overall mean communication assessment tool score and the percentage of excellent rating.Conclusion: Study findings provided high patient satisfaction with their physicians’ communication skills. However, diabetes and metabolic control were not affected by this satisfaction. Hence, improvement in the communication skills of the physicians is recommended.

  • Open Access

    Neonatal Outcomes in Patients with Gestational Diabetes Mellitus Treated with Metformin: A Retrospective Study in Saudi Arabia

    byĀ Khaled H. Aburisheh, Mazen M. Barhoush, Abdulaziz N. Alahmari, Ziyad A. Altasan, Muffarah H. Alharthi

    Background: Gestational diabetes mellitus (GDM) is a common endocrine disease that can occur during pregnancy, increasing the risk of fetal morbidity and mortality. Metformin is a commonly used therapeutic approach for managing GDM. However, there is controversy regarding the effects of metformin on fetal outcomes during pregnancy. This study aimed to evaluate the safety of metformin in relation to neonatal complications, compared to treatment with insulin and/or specialized diets. Method: This was a retrospective study that included pregnant women who were diagnosed with GDM and treated with specialized diets, metformin, or insulin. Data were collected from patients’ electronic medical records and analyzed to evaluate the risk of neonatal outcomes in the metformin group compared to the others. Results: The study included 234 women with GDM. There was no difference between the metformin and insulin groups in terms of the rates of neonatal outcomes, while neonatal hypoglycemia, neonatal hyperbilirubinemia, large for gestational age, and respiratory distress were higher in the metformin group when compared to the diet group. Metformin slightly increased the risk of a lower APGAR score compared to diet alone. Conclusions: Metformin was found to be a safe therapy for the fetus when used to manage GDM, compared to insulin therapy. More randomized studies are needed to confirm these findings in the Saudi population.


  • Open Access

    Toll-like Receptor 9 Gene in the Development of Type 2 Diabetes Mellitus in the Saudi Arabian Population

    byĀ Zeina S. Alkudmani, Aminah Ahmad Alzailai, Khaled H. Aburisheh, Amal F. Alshammary, Imran Ali Khan

    Diabetes mellitus is a complex disease with a wide range of manifestations. Diabetes, notably type 2 diabetes mellitus (T2DM), is becoming more common in Saudi Arabia as a result of obesity and an aging population. T2DM is classified as a noncommunicable disease, and its incidence in the Saudi population continues to grow as a consequence of socioeconomic changes. Toll-like receptors (TLRs) are innate immune receptors that mediate the inflammatory response in diabetes mellitus. Previous studies have documented the relationship between different SNPs in the TLR9 gene in different forms of diabetes. As a result, the purpose of this study was to investigate the relationship between rs187084, rs352140, and rs5743836 SNPs in the TLR9 gene among T2DM patients in the Saudi population. This was a case-control study that included 100 T2DM cases and 100 control subjects. The three SNPs were identified in the study population (n = 200) using polymerase chain reaction (PCR), restriction enzymes for rs352140, and Sanger sequencing for rs187084 and rs5783836. Next, statistical analyses were performed using various software to determine the association between the SNPs and T2DM. rs187084 and rs5743836 were associated with an increased risk of T2DM development. rs187084 and rs5743836 allelic frequencies were associated with a 3.2 times increased risk of T2DM development (p < 0.05). DBP was associated with T2DM (p = 0.02). rs187084 was associated with TC and HDLc; rs352140 was associated with DBP, HbA1c, and HDLc; rs5743836 was associated with waist (p < 0.05). The CGT haplotype was strongly associated with T2DM (p < 0.003). Gene–gene interaction, graphical presentation, and dendrogram showed the strong association with T2DM patients (p < 0.05). This study concluded that rs187084 and rs5743836 were strongly associated with T2DM in Saudi Arabian patients. This study provides further evidence that SNPs in the TLR9 gene play a significant role in T2DM development in a Saudi community.


  • Open Access

    Echocardiographic Changes in Saudi Patients with Type 2 Diabetes Mellitus

    byĀ Turky H. Almigbal, Dina S. Almunif, Khaled H. Aburisheh, Mazen M. Barhoush, Reem A. Aldhahi, Mohammed J. Anabi, Obeed A. Alotaibi

    Background and Objectives: Cardiovascular disease is one of the leading causes of morbidity and mortality among the diabetic population. Given the high prevalence of diabetes mellitus (DM) in Saudi Arabia and the high prevalence of heart failure in the diabetic population, this study assesses the echocardiographic changes in Saudi patients with type 2 DM (T2DM) compared with healthy controls. Materials and Methods: In this retrospective case–control study, 80 patients with diabetes (45 males, age: 58.78 ± 10.2 years) were compared with 80 controls (45 males, age: 58.6 ± 10 years) who underwent an echocardiographic study in the King Saud University Medical City, Riyadh, Saudi Arabia. Results: There were no significant differences between the patients with diabetes and controls in terms of aortic root diameter, left atrium diameter, posterior wall, interventricular wall thickness, left ventricular diameters and ejection fraction. However, diastolic dysfunction was statistically significantly higher in the diabetic group than in the control group (p < 0.05). Conclusions: This is the first case–control study in Saudi Arabia that assesses echocardiographic parameters in T2DM patients. DM is an independent risk factor for diastolic dysfunction regardless of its association with hypertension and dyslipidemia.